Cargando…

Near‐infrared photoimmunotherapy targeting EGFR—Shedding new light on glioblastoma treatment

Glioblastomas (GBMs) are high‐grade brain tumors, differentially driven by alterations (amplification, deletion or missense mutations) in the epidermal growth factor receptor (EGFR), that carry a poor prognosis of just 12–15 months following standard therapy. A combination of interventions targeting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burley, Thomas A., Mączyńska, Justyna, Shah, Anant, Szopa, Wojciech, Harrington, Kevin J., Boult, Jessica K.R., Mrozek‐Wilczkiewicz, Anna, Vinci, Maria, Bamber, Jeffrey C., Kaspera, Wojciech, Kramer‐Marek, Gabriela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Cancer Therapy and Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016485/ https://www.ncbi.nlm.nih.gov/pubmed/29313975 http://dx.doi.org/10.1002/ijc.31246

Ejemplares similares

Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy
por: Mączyńska, Justyna, et al.
Publicado: (2022)

Correction: Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy
por: Mączyńska, Justyna, et al.
Publicado: (2022)

Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives
por: Szopa, Wojciech, et al.
Publicado: (2017)

Antibody Drug Conjugates of Near-Infrared Photoimmunotherapy (NIR-PIT) in Breast Cancers
por: Cui, Yingshu, et al.
Publicado: (2023)

Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy
por: Furumoto, Hideyuki, et al.
Publicado: (2022)

Efficacy and safety of osimertinib in treating EGFR‐mutated advanced NSCLC: A meta‐analysis
por: Yi, Lilan, et al.
Publicado: (2019)

Near-Infrared Photoimmunotherapy of Cancer
por: Kobayashi, Hisataka, et al.
Publicado: (2019)

Near‐infrared photoimmunotherapy through bone
por: Nakamura, Yu A., et al.
Publicado: (2019)

Near-Infrared Photoimmunotherapy for Oropharyngeal Cancer
por: Nishikawa, Daisuke, et al.
Publicado: (2022)

Near infrared photoimmunotherapy with an anti-mesothelin antibody
por: Nagaya, Tadanobu, et al.
Publicado: (2016)

Expanding the application of cancer near-infrared photoimmunotherapy
por: Kobayashi, Hisataka
Publicado: (2021)

Isolated limb perfusion with biochemotherapy and oncolytic virotherapy combines with radiotherapy and surgery to overcome treatment resistance in an animal model of extremity soft tissue sarcoma
por: Wilkinson, Michelle J., et al.
Publicado: (2016)

Near infrared photoimmunotherapy for cancers: A translational perspective
por: Maruoka, Yasuhiro, et al.
Publicado: (2021)

Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers
por: Fukushima, Hiroshi, et al.
Publicado: (2022)

Near infrared photoimmunotherapy of cancer; possible clinical applications
por: Wakiyama, Hiroaki, et al.
Publicado: (2021)

Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen
por: Nagaya, Tadanobu, et al.
Publicado: (2015)

Immunomodulatory activity of IR700-labelled affibody targeting HER2
por: Mączyńska, Justyna, et al.
Publicado: (2020)

Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy
por: Mitsunaga, Makoto, et al.
Publicado: (2012)

Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody
por: Nagaya, Tadanobu, et al.
Publicado: (2018)

Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials
por: Okada, Ryuhei, et al.
Publicado: (2021)

Near-infrared photoimmunotherapy: a comparison of light dosing schedules
por: Ogata, Fusa, et al.
Publicado: (2017)

Near Infrared Photoimmunotherapy; A Review of Targets for Cancer Therapy
por: Kato, Takuya, et al.
Publicado: (2021)

Near-Infrared Photoimmunotherapy for Thoracic Cancers: A Translational Perspective
por: Matsuoka, Kohei, et al.
Publicado: (2022)

In Vitro Comparative Study of Near-Infrared Photoimmunotherapy and Photodynamic Therapy
por: Yamashita, Susumu, et al.
Publicado: (2023)

Sorafenib with ASC‐J9(®) synergistically suppresses the HCC progression via altering the pSTAT3‐CCL2/Bcl2 signals
por: Xu, Junjie, et al.
Publicado: (2016)

Use of thermo‐coagulation as an alternative treatment modality in a ‘screen‐and‐treat’ programme of cervical screening in rural Malawi
por: Campbell, Christine, et al.
Publicado: (2016)

Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single‐arm study
por: Pan, Zhenyu, et al.
Publicado: (2016)

Dosing targeted and cytotoxic two‐drug combinations: Lessons learned from analysis of 24,326 patients reported 2010 through 2013
por: Nikanjam, Mina, et al.
Publicado: (2016)

Phase II study of the effectiveness and safety of trastuzumab and paclitaxel for taxane‐ and trastuzumab‐naïve patients with HER2‐positive, previously treated, advanced, or recurrent gastric cancer (JFMC45‐1102)
por: Nishikawa, Kazuhiro, et al.
Publicado: (2016)

Combination therapy with zoledronic acid and cetuximab effectively suppresses growth of colorectal cancer cells regardless of KRAS status
por: Kato, Junko, et al.
Publicado: (2016)

A randomized, placebo‐controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild‐type KRAS who have received first‐line systemic therapy
por: Eng, Cathy, et al.
Publicado: (2016)

Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo
por: Voloshin, Tali, et al.
Publicado: (2016)

Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women
por: Gultekin, Murat, et al.
Publicado: (2017)

Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration‐resistant prostate cancer models
por: Luo, Yong, et al.
Publicado: (2018)

The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated‐recombinant arginase I BCT‐100
por: De Santo, Carmela, et al.
Publicado: (2017)

Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study
por: Sun, Zimin, et al.
Publicado: (2018)

Bepridil exhibits anti‐leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia
por: Baldoni, Stefano, et al.
Publicado: (2018)

The effect of FASN inhibition on the growth and metabolism of a cisplatin‐resistant ovarian carcinoma model
por: Papaevangelou, Efthymia, et al.
Publicado: (2018)

Phase Ib/II study of safety and efficacy of low‐dose decitabine‐primed chemoimmunotherapy in patients with drug‐resistant relapsed/refractory alimentary tract cancer
por: Chen, Meixia, et al.
Publicado: (2018)

Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up
por: De Strooper, Lise M.A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i2frlcuehk6kp53rjepnm2i058